(Q37571970)

21 August 2017

1 reference

title

Emerging gene-directed anti-tumor strategies against human hepatoblastoma (English)

1 reference

21 August 2017

Steven W Warmann

1

1 reference

21 August 2017

Jörg Fuchs

series ordinal

2

1 reference

21 August 2017

Michael Bitzer

series ordinal

3

1 reference

21 August 2017

Ulrich M Lauer

series ordinal

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Biological Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

1155-1161

1 reference

Hepatoblastoma incidence in the United States from 1973 to 1992.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

21 January 2018

Liver tumors in children

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Cisplatin-resistant metastatic hepatoblastoma: complete response to carboplatin, etoposide, and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma--a report from the German Cooperative Pediatric Liver Tumor Study HB-89.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Drug resistance in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Blocking the hedgehog pathway inhibits hepatoblastoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Association between hepatoblastoma and polyposis coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Elevated expression of Wnt antagonists is a common event in hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Cytogenetics of hepatoblastoma: further characterization of 1q rearrangements by fluorescence in situ hybridization: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Specific gene transfer mediated by galactosylated poly-L-lysine into hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Efficient gene transfer to hepatoblastoma cells through asialoglycoprotein receptor and expression under the control of the cyclin A promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

New trends in tumor biology: transfection of a human hepatoblastoma cell line with green fluorescent protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

In vitro gene targeting in human hepatoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Optimizing vector application for gene transfer into human hepatoblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Evaluation of bcl-2 gene expression in papilloma of larynx in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Bcl-2 gene silencing in pediatric epithelial liver tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Bcl-2 siRNA induced apoptosis and increased sensitivity to 5-fluorouracil and HCPT in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Suicide genes: past, present and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Adenovirus-mediated cytosine deaminase/5-fluorocytosine suicide gene therapy of human hepatoblastoma in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Genetic manipulation of non-segmented negative-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903136696

10.1517/14712590903136696

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference